Biotransformations of Drugs and Chemicals
71
CYP2C19 inhibition evaluation,
J.
Pharm.
Biochem. Anal.
25
, 437–442.
Cashman, J.R. (2000) Flavin monooxygenase:
substrate
specifcity
and
role
in
drug
metabolism,
Curr. Drug Metab.
1
, 181–191.
Dashwood, R.H.,
Arbogast, D.N.,
Fong, A.T.,
Pereira, C.,
Hendricks,
J.D.,
Bailey,
G.S.
(1989) Quantitative interrelationships between
aflatoxin
B1
carcinogen
dose,
indole-3-
carbinol anticarcinogen dose, target organ
DNA adduction and fnal tumor response,
Carcinogenesis
10
, 175–181.
Denison, M.S., Nagy, S.R. (2003) Activation o±
the aryl hydrocarbon receptor by structurally
diverse exogenous and endogenous chemicals,
Annu. Rev. Pharmacol. Toxicol.
43
, 309–334.
Denissenko, M.F., Pao, A., Tang, M., P±ei±er, G.P.
(1996) Pre±erential ±ormation o± Benzo[a]py-
rene
adducts
at
lung
cancer
mutational
hotspots in P53,
Science
274
, 430–432.
Drey±uss,
J.,
Ross,
J.J.
Jr.,
Shaw,
J.M.,
Miller, I., Schreiber, E.C. (1976) Release and
elimination o±
14
C-fluphenazine enanthate
and decanoate esters administered in sesame
oil to dogs,
J. Pharm. Sci.
65
, 502–507.
Fadominska-Pandya, A., Czernik, P.J., Little,
J.M.,
Battaglia, E.,
Mackenzie, P.I.
(1999)
Structural and ±unctional studies o± UDP-
glucuronosyltrans±erases,
Drug. Metab. Rev.
31
, 817–899.
Faigle, J.W., Dieterle, W. (1977) The biotrans±or-
mation o± phenylbutazone (Butazolidin),
J. Int.
Med. Res.
5
(Suppl. 2), 2–14.
Fretland, A.J., Omiecinski, C.J. (2000) Epoxide
hydrolases:
biochemistry
and
molecular
biology,
Chem. Biol. Interact.
129
, 41–59.
G
e
r
h
o
l
d
,D
.
,L
u
,M
.
,X
u
,J
.
,A
u
s
t
i
n
,C
.
,
Caskey, C.T., Rushmore, T. (2001) Monitoring
expression
genes
involved
in
drug
metabolism
and
toxicology
using
DNA
microarrays,
Physiol. Genomics
5
, 161–170.
Gordon, E.R., Sommerer, U., Goresky, C.A.
(1983) The hepatic microsomal ±ormation o±
bilirubin diglucuronide,
J. Biol. Chem.
258
,
15028–15036.
Hempel, J., Perozich, J., Chapman, T., Rose, J.,
Boesch, J.S., Liu, Z.J., Lindahl, R., Wang, B.C.
(1999)
Aldehyde
dehydrogenase
catalytic
mechanism. A proposal,
Adv. Exp. Med. Biol.
463
, 53–59.
Hirshey, S.J., Dooley, T.P., Reardon, I.M., Hein-
rikson, R.L.,
Falany, C.N.
(1992)
Sequence
analysis,
in vitro
translation, and expression
o± the cDNA ±or rat liver minoxidil sul±otrans-
±erase,
Mol. Pharmacol.
42
, 257–264.
html.
Idle, J.R., Mahgoub, A., Lancaster, R., Smith, R.L.
(1978) Hypotensive response to debrisoquine
and hydroxylation phenotype,
Life Sci
.
22
,
889–904.
Janssen, F.W.,
Kirkman, S.K.,
Knowles, J.A.,
Ruelius, H.W.
(1978)
Disposition
4,5-
diphenyl-2-oxazolepropionic acid (oxaprozin)
in beagle dogs and rhesus monkeys,
Drug
Metab. Dispos.
6
, 465–475.
Jerina, D.M., Daly, J.W. (1974) Arene oxides: a
new aspect o± drug metabolism,
Science
185
,
573–582.
Jornvall, H., Hoog, J.O., Persson, B., Pares, X.
(2000)
Pharmacogenetics
the
alcohol
dehydrogenase
system,
Pharmacology
61
,
184–191.
Knecht, K.T., Mason, R.P. (1988)
In vivo
radical
trapping
and
biliary
secretion
radical
adducts o± carbon tetrachloride-derived ±ree
radical metabolites,
Drug Metab. Dispos.
16
,
813–817.
Lam, J.P., Mays, D.C., Lipsky, J.J. (1997) Inhibi-
tion o± recombinant human mitochondrial and
cytosolic aldehyde dehydrogenases by two can-
didates ±or the active metabolites o± disulfram,
Biochemistry
36
, 13748–13754.
Le
Bigot,
J.F.,
Cresteil,
T.,
Kiechel,
J.R.,
Beaune, P. (1983) Metabolism o± ketoti±en
by
human
liver
microsomes.
In
vitro
characterization
a
tertiary
amine
glucuronidation,
Drug
Metab.
Dispos.
11
,
585–589.
Lin, J. (1995) Species similarities and di±±erences
in pharmacokinetics,
Drug Metab. Dipos.
23
,
1008–1021.
Lin, J.H., Levy, G. (1986) E±±ect o± prevention
inorganic
sul±ate
depletion
on
the
pharmacokinetics o± acetaminophen in rats,
J. Pharmacol. Exp. Ther.
239
, 94–98.
Mackenzie, P., Owens, I., Burchell, B., Bock, K.,
Bairoch, A., B´elanger, A., Fournel-Gigleux, S.,
Green, M., Hum, D., Iyanagi, T., Lancet, D.,
Louisot, P., Magdalou, J., Chowdhury, J., Rit-
ter, J., Schachter, H., Tephly, T., Tipton, K.,
Nebert, D. (1997) The UDP glycosyltrans±erase
gene super±amily: recommended nomencla-
ture update based on evolutionary divergence,
Pharmacogenetics
7
, 255–269.
previous page 745 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online next page 747 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online Home Toggle text on/off